Phase I Trial of IL13Rα2-Targeted CAR T-cell Therapy for Recurrent Malignant Glioma: Clinical Results and Pharmacokinetics.
Saved in:
| Title: | Phase I Trial of IL13Rα2-Targeted CAR T-cell Therapy for Recurrent Malignant Glioma: Clinical Results and Pharmacokinetics. |
|---|---|
| Authors: | Kim K; R&D center, CellabMED Inc., Seoul, Republic of Korea., Song SW; CellabMED Inc., Seoul, Republic of Korea., Jeon Y; R&D center, CellabMED Inc., Seoul, Republic of Korea., Choi S; R&D center, CellabMED Inc., Seoul, Republic of Korea., Choi J; R&D center, CellabMED Inc., Seoul, Republic of Korea., Jun S; R&D center, CellabMED Inc., Seoul, Republic of Korea., Park JH; CGT center, CellabMED Inc., Seoul, Republic of Korea., Lee SJ; CGT center, CellabMED Inc., Seoul, Republic of Korea., Han N; Department of Pathology and Translational Genomics, Samsung Medical Center, Seoul, Republic of Korea., Dho YS; Neuro-oncology clinic, National Cancer Center, Goyang, Republic of Korea., Shin SH; Neuro-oncology clinic, National Cancer Center, Goyang, Republic of Korea., Yoo H; Neuro-oncology clinic, National Cancer Center, Goyang, Republic of Korea., Wang KC; Neuro-oncology clinic, National Cancer Center, Goyang, Republic of Korea., Gwak HS; Neuro-oncology clinic, National Cancer Center, Goyang, Republic of Korea.; Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Republic of Korea. |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Oct 15; Vol. 32 (20), pp. 4656-4667. |
| Publication Type: | Journal Article; Clinical Trial, Phase I |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
